Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review
- PMID: 35873068
- PMCID: PMC9275414
Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review
Abstract
Background: The COVID-19 pandemic has affected the entire world tremendously. Particularly during the second wave in India, a dangerous complication followed in the form of COVID-19-associated mucormycosis. On June 7th, 2021, the Indian Union Health Minister stated that 28,252 cases of mucormycosis were reported from 28 states/Union territories in the country.
Methods: A PubMed search was conducted for English-language studies published from 1988 through May 22, 2021 using the terms "reconstruction AND mucormycosis."
Results: The search yielded 102 results. After excluding the articles not describing reconstruction in mucormycosis, 53 abstracts were screened. Then 34 articles dealing with reconstruction in non-ROC regions were excluded. The full text of 16 articles was reviewed. Additionally, 3 articles were identified from the reference search. Due to the aggressive debridements, rhino-orbito-cerebral mucormycosis survivors may be left with complex tissue defects with significant functional and aesthetic impairments. It is essential to offer reconstructive solutions that improve their quality of life. As far as the timing of reconstruction is concerned, the consensus is in favor of delayed reconstruction after ensuring that the infection has been eliminated/controlled and that there are no recurrences. The most common defects encountered were the ones that resulted from orbital exenteration and excision of a varying extent of the involved contiguous bony and soft tissue structures. Reconstruction with pedicled flaps was preferred rather than free flaps, especially in the cases where the infection was not eliminated completely. Adjuvant antifungal therapy was used in most of the cases. Long-term follow-up was considered essential to detect and treat recurrences.
Conclusions: A multitude of options are available for reconstruction in rhino-orbito-cerebral mucormycosis including skin grafts, pedicled flaps, free flaps and in some cases implants and prosthetics. These can be utilized to give as much as functional and aesthetic restoration as possible to the patient.
Keywords: COVID-19; free tissue flaps; mucormycosis; orbit evisceration; quality of life.
© 2022, HMP Global. All rights reserved. Reproduction in whole or in part prohibited. Content may not be reproduced in any form without written permission. Rights, Permission, Reprint, and Translation information is available at www.hmpglobal.com.
Figures


Similar articles
-
Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap.Indian J Plast Surg. 2024 Apr 23;57(5):379-386. doi: 10.1055/s-0044-1785489. eCollection 2024 Oct. Indian J Plast Surg. 2024. PMID: 39552810 Free PMC article.
-
Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.J Maxillofac Oral Surg. 2023 Mar 13:1-22. doi: 10.1007/s12663-023-01878-8. Online ahead of print. J Maxillofac Oral Surg. 2023. PMID: 37362874 Free PMC article. Review.
-
Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3492-3497. doi: 10.1007/s12070-021-02978-y. Epub 2021 Nov 12. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 34786356 Free PMC article.
-
Rhino-Orbito-Cerebral Mucormycosis: Two Cases with Amaurosis as Presentation, Medical Surgical Management and Follow-Up.Case Rep Ophthalmol Med. 2019 Dec 5;2019:4215989. doi: 10.1155/2019/4215989. eCollection 2019. Case Rep Ophthalmol Med. 2019. PMID: 31885978 Free PMC article.
-
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.Indian J Pharmacol. 2021 Jul-Aug;53(4):317-327. doi: 10.4103/ijp.ijp_419_21. Indian J Pharmacol. 2021. PMID: 34414911 Free PMC article.
Cited by
-
Health-related quality of life after prosthodontic rehabilitation in patients with COVID-19-associated mucormycosis: A systematic review.J Indian Prosthodont Soc. 2025 Jan 1;25(1):30-39. doi: 10.4103/jips.jips_202_24. Epub 2025 Jan 3. J Indian Prosthodont Soc. 2025. PMID: 40654120 Free PMC article.
-
Surgical Rehabilitation of a Continuous Orbital and Maxillary Defect from Rhino-Orbital Mucormycosis Utilising Digital Technology - A Case Report.Ann Maxillofac Surg. 2023 Jul-Dec;13(2):224-227. doi: 10.4103/ams.ams_54_23. Epub 2023 Oct 23. Ann Maxillofac Surg. 2023. PMID: 38405554 Free PMC article.
-
Restoring Quality of Life: Assessing the Impact of Free Flap Reconstruction in Coronavirus Disease 2019-Associated Rhino-Orbital Mucormycosis Patients.Indian J Plast Surg. 2023 Oct 16;56(6):507-513. doi: 10.1055/s-0043-1776011. eCollection 2023 Dec. Indian J Plast Surg. 2023. PMID: 38105868 Free PMC article.
-
A case report on clinical features, diagnosis, and treatment of rhino-orbito-cerebral mucormycosis.Immun Inflamm Dis. 2023 Nov;11(11):e1080. doi: 10.1002/iid3.1080. Immun Inflamm Dis. 2023. PMID: 38018593 Free PMC article. Review.
-
Post-COVID-19 Rhino-Orbito-Maxillary Mucormycosis Defect: Our Surgical Experience with Single Stage Delayed Reconstruction Using Free Flap.Indian J Plast Surg. 2024 Apr 23;57(5):379-386. doi: 10.1055/s-0044-1785489. eCollection 2024 Oct. Indian J Plast Surg. 2024. PMID: 39552810 Free PMC article.
References
-
- Ritchie H, Ortiz-Ospina E, Beltekian D, et al. . Coronavirus Pandemic (COVID-19). Our World Data. Published online March 5, 2020. https://ourworldindata.org/covid-deaths. Accessed July 11, 2021.
-
- Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?. Lancet Respir Med. 2021;9(8):e77. doi:10.1016/S2213-2600(21)00265-410.1016/S2213-2600(21)00265-4 - DOI - DOI - PMC - PubMed
-
- Singh P. Black fungus: Here is a list of states with highest number of mucormycosis cases. Hindustan Times. Published May 21, 2021. https://www.hindustantimes.com/india-news/black-fungus-states-with-highe.... Accessed June 17, 2021.
-
- Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. doi:10.1016/j.dsx.2021.05.01910.1016/j.dsx.2021.05.019 - DOI - DOI - PMC - PubMed
-
- Zee Media Bureau. 28,252 mucormycosis cases with 86% history of COVID from 28 states/UTs: Harsh Vardhan. Zee News. Published June 7, 2021. https://zeenews.india.com/india/28252-mucormycosis-cases-with-86-history.... Accessed June 17, 2021.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials